 WALTHAM, Mass., Dec. 30, 2020 GLOBE NEWSWIRE -- Morphic Therapeutic Nasdaq: MORF, a biotechnology company developing oral integrin therapies, today announced that Praveen Tipirneni, M.D., president and chief executive officer, will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 4:30 PM ET. 